Community-acquired pneumonia: Tailoring management of adult patients according to risk category

Postgraduate Medicine

Volumn 102, Issue 6, 1997, Pages 45-47

  Rubins, Jeffrey B ^a   Janoff, Edward N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIVIRUS AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; RIFAMPICIN; RIMANTADINE; SULFONAMIDE; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; TIMENTIN;

ANTIBIOTIC THERAPY; ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRACTICE GUIDELINE; PULSE OXIMETRY; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

EID: 0031449966     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.12.382     Document Type: Article

References (14)

1. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Official statement of American Thoracic Society. Am Rev Respir Dis 1993;148(5): 1418-26
2. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18(4):501-15
3. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333(24):1618-24
4. MacDonald KS, Scriver SR, Skulnick M, et al. Community-acquired pneumonia: the future of the microbiology laboratory: focused diagnosis or syndromic management? Semin Respir Infect 1994;9(3):180-8
5. Fine MJ, Singer DE, Hanusa BH, et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1993;94(2): 153-9
6. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996;275(2):134-41
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336(4):243-50
8. Ewig S, Bauer T, Hasper E, et al. Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur Respir J 1995; 8(3):392-7
9. Heckerling PS, Tape TG, Wigton RS, et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med 1990; 113(9):664-70
10. Centers for Disease Control and Prevention. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR 1993;42(RR-2):1-6
11. Leeper KV, Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995;16(1);155-71
12. Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995; 155(12):1273-6
13. Mittl RL Jr, Schwab RJ, Duchin JS, et al. Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med 1994;149(3 Pt 1):630-5
14. Marrie TJ. Pneumonia and carcinoma J of the lung. J Infect 1994;29(1):45-52